Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 August 2023

Sporadic disruptions of academic activities occurred yesterday and this morning on the Bloemfontein, South and Qwaqwa Campuses.

In recent weeks, the university management has made various attempts to keep the campuses open for face-to-face learning and teaching amid challenges experienced with the disbursement of students’ National Student Financial Aid Scheme (NSFAS) allowances through eZaga, an online digital banking service, tasked with dispersing direct payments to NSFAS beneficiaries.

These attempts include, but are not limited to, the attendance of meetings by UFS representatives with NSFAS, arranged by Universities South Africa (USAf); meetings with NSFAS attended by Prof Francis Petersen, Vice-Chancellor and Principal; constant engagements with NSFAS by the university’s Financial Aid Office; a meeting with the Minister of Higher Education, Science and Innovation, Dr Blade Nzimande, to discuss the matter – this was postponed to a later date; constant engagements with the Institutional Student Representative Council (ISRC) on matters relating to NSFAS, etc. These attempts are, however, not acceptable to our students.

To minimise the risk to the academic programme, as well as the fact that this is a sector-wide challenge, the academic programme, (activities, classes, and assignments) will continue online as far as possible from 2 to 4 August 2023. Further information about students’ online academic programme will be communicated by the respective faculties.

The university management would like to thank our academic staff for their commitment during this time, and for ensuring that the academic programme continues through online delivery.

The university is not closed; all other activities will continue as normal.  All campuses are also accessible. The situation on the campuses is being monitored closely and the necessary security measures are in place to ensure the safety of students and staff.

The university’s protocol during protests provides guidance to students and staff on how to act during protests.

Students and staff will be updated on the situation.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept